Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome

Adam S. Kittai; David A. Bond; Basem William; Ayman Saad; Sam Penza; Yvonne Efebera; Karilyn Larkin; Sarah A. Wall; Hannah K. Choe; Bhavana Bhatnagar; Sumithira Vasu; Jonathan Brammer; Polina Shindiapina; Meixiao Long; Alice Mims; Lynn O'Donnell; Seema A. Bhat; Kerry A. Rogers; Jennifer A. Woyach; John C. Byrd; Samantha M. Jaglowski

doi:10.1182/bloodadvances.2020002783

Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome

Adam S. Kittai
, David A. Bond
, Basem William
, Ayman Saad
, Sam Penza
, Yvonne Efebera
, Karilyn Larkin
, Sarah A. Wall
, Hannah K. Choe
, Bhavana Bhatnagar
, Sumithira Vasu
, Jonathan Brammer
, Polina Shindiapina
, Meixiao Long
, Alice Mims
, Lynn O'Donnell
, Seema A. Bhat
, Kerry A. Rogers
, Jennifer A. Woyach
, John C. Byrd

Samantha M. Jaglowski

Research output: Contribution to journal › Comment/debate

68 Scopus citations

Original language	English
Pages (from-to)	4648-4652
Number of pages	5
Journal	Blood Advances
Volume	4
Issue number	19
DOIs	https://doi.org/10.1182/bloodadvances.2020002783
State	Published - Oct 13 2020

Access to Document

10.1182/bloodadvances.2020002783

Cite this

Kittai, A. S., Bond, D. A., William, B., Saad, A., Penza, S., Efebera, Y., Larkin, K., Wall, S. A., Choe, H. K., Bhatnagar, B., Vasu, S., Brammer, J., Shindiapina, P., Long, M., Mims, A., O'Donnell, L., Bhat, S. A., Rogers, K. A., Woyach, J. A., ... Jaglowski, S. M. (2020). Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome. Blood Advances, 4(19), 4648-4652. https://doi.org/10.1182/bloodadvances.2020002783

@article{3770ce16d62c47648faa808aac601fc1,

title = "Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome",

author = "Kittai, \{Adam S.\} and Bond, \{David A.\} and Basem William and Ayman Saad and Sam Penza and Yvonne Efebera and Karilyn Larkin and Wall, \{Sarah A.\} and Choe, \{Hannah K.\} and Bhavana Bhatnagar and Sumithira Vasu and Jonathan Brammer and Polina Shindiapina and Meixiao Long and Alice Mims and Lynn O'Donnell and Bhat, \{Seema A.\} and Rogers, \{Kerry A.\} and Woyach, \{Jennifer A.\} and Byrd, \{John C.\} and Jaglowski, \{Samantha M.\}",

note = "Funding Information: Conflict-of-interest disclosure: D.A.B. received travel funding from Novartis and receives research funding from Bristol-Myers Squibb. B.W. receives research support from Incyte, Dova, and Merck; consulted for Guidepoint Global and Techspert; and is on the advisory board for Kyowa Kirin. A.S. receives research support from Amgen, Kadmon, and OrcaBio, and consulted for Magenta Therapeutics. B.B. receives research support from Karyopharm Therapeutics and Cell Therapeutics, and is on the advisory board for Novartis, Astellas, Kite, and Cell Therapeutics. S.V. participated in the advisory board of Omeros Therapeutics, and receives research support from Kiadis Inc. P.S. receives research support from Seattle Genetics via contractor company Leidos Biomedical Research Inc. A.M. consulted for AbbVie, Agios, Astellas, Jazz, and PTC Therapeutics. L.O. is the vice president of the International Society of Cell and Gene Therapy, and is a member of their board of directors. S.A.B. participated in advisory boards for Pharmacyclics and Jansen. K.A.R. receives research funding from Genentech, AbbVie, and Janssen; participated in advisory boards for Acerta Pharma, AstraZeneca, and Pharmacyclics; and received travel funding from AstraZeneca. J.A.W. receives research laboratory support from Loxo and AbbVie, and consulted for Pharmacyclics,",

year = "2020",

month = oct,

day = "13",

doi = "10.1182/bloodadvances.2020002783",

language = "English",

volume = "4",

pages = "4648--4652",

journal = "Blood Advances",

issn = "2473-9529",

number = "19",

}

Kittai, AS, Bond, DA, William, B, Saad, A, Penza, S, Efebera, Y, Larkin, K , Wall, SA , Choe, HK, Bhatnagar, B, Vasu, S , Brammer, J , Shindiapina, P , Long, M , Mims, A , O'Donnell, L , Bhat, SA , Rogers, KA , Woyach, JA, Byrd, JC & Jaglowski, SM 2020, 'Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome', Blood Advances, vol. 4, no. 19, pp. 4648-4652. https://doi.org/10.1182/bloodadvances.2020002783

TY - JOUR

T1 - Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome

AU - Kittai, Adam S.

AU - Bond, David A.

AU - William, Basem

AU - Saad, Ayman

AU - Penza, Sam

AU - Efebera, Yvonne

AU - Larkin, Karilyn

AU - Wall, Sarah A.

AU - Choe, Hannah K.

AU - Bhatnagar, Bhavana

AU - Vasu, Sumithira

AU - Brammer, Jonathan

AU - Shindiapina, Polina

AU - Long, Meixiao

AU - Mims, Alice

AU - O'Donnell, Lynn

AU - Bhat, Seema A.

AU - Rogers, Kerry A.

AU - Woyach, Jennifer A.

AU - Byrd, John C.

AU - Jaglowski, Samantha M.

N1 - Funding Information: Conflict-of-interest disclosure: D.A.B. received travel funding from Novartis and receives research funding from Bristol-Myers Squibb. B.W. receives research support from Incyte, Dova, and Merck; consulted for Guidepoint Global and Techspert; and is on the advisory board for Kyowa Kirin. A.S. receives research support from Amgen, Kadmon, and OrcaBio, and consulted for Magenta Therapeutics. B.B. receives research support from Karyopharm Therapeutics and Cell Therapeutics, and is on the advisory board for Novartis, Astellas, Kite, and Cell Therapeutics. S.V. participated in the advisory board of Omeros Therapeutics, and receives research support from Kiadis Inc. P.S. receives research support from Seattle Genetics via contractor company Leidos Biomedical Research Inc. A.M. consulted for AbbVie, Agios, Astellas, Jazz, and PTC Therapeutics. L.O. is the vice president of the International Society of Cell and Gene Therapy, and is a member of their board of directors. S.A.B. participated in advisory boards for Pharmacyclics and Jansen. K.A.R. receives research funding from Genentech, AbbVie, and Janssen; participated in advisory boards for Acerta Pharma, AstraZeneca, and Pharmacyclics; and received travel funding from AstraZeneca. J.A.W. receives research laboratory support from Loxo and AbbVie, and consulted for Pharmacyclics,

PY - 2020/10/13

Y1 - 2020/10/13

UR - https://www.scopus.com/pages/publications/85092369159

U2 - 10.1182/bloodadvances.2020002783

DO - 10.1182/bloodadvances.2020002783

M3 - Comment/debate

C2 - 33002129

AN - SCOPUS:85092369159

SN - 2473-9529

VL - 4

SP - 4648

EP - 4652

JO - Blood Advances

JF - Blood Advances

IS - 19

ER -

Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome

Access to Document

Other files and links

Cite this